2,4,6-Tris(4-butoxy-2-hydroxyphenyl)-1,3,5-triazine>98.0%(HPLC)(N)1g

(1-(1-ETHOXY-1-OXOBUTAN-2-YL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER, 95.0%, 5g

N-Methyl-1H-pyrazol-3-amine, 95.0%, 250mg

4-Amino-3-iodobenzoic acid, 97.0%, 10g

4-Bromo-1,3-dimethyl-1H-pyrazole, 95.0%, 5g

(S)-tert-Butyl 4-(4-(4-(2-amino-3-methoxy-3-oxopropyl)phenoxy)butyl)piperidine-1-carboxylate, 97%, 1g

2-Pentyl benzyl sulfide, 98.0%, 5g

4-FLUORO-3-IODO-1-METHYL-1H-INDAZOLE, 95.0%, 5g

Zentrifugenflaschen aus PPCO, Vol. 500 ml, 4 Stück

4,9-Dibromonaphtho[2,3-c][1,2,5]selenadiazole, 95%, 1g

2,7-Dimethoxy-quinoline-3-carbaldehyde, 95.0%, 1g

4-(Benzyloxy)-2,6-dichloropyridine, 98%, 10g

(S)-Ethyl 2-((tert-butoxycarbonyl)amino)-4-iodobutanoate, 95%, 1g